Japan's Astellas Pharma inks $400 M deal with AI Proteins to develop novel miniprotein-based therapeutics – BioSpectrum Asia
27 minutes ago · Google News - Japan
Global Japan
& newspaper;
Read Full Article →
Sourced From
Google News - Japan
Japan's Astellas Pharma inks $400 M deal with AI Proteins to develop novel miniprotein-based therapeutics BioSpectrum Asia
Source: Google News – Japan — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: Google News - Japan — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.